As of Mar 27
| +0.31 / +13.84%|
The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +449.02% increase from the last price of 2.55.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.